SCHEMBL6638588

SCHEMBL6638588

Cn1c(CCc2ccc(C#N)cc2)nc2cc(N)cnc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ ALOX5AP P20292 4/20 0.39
▸ BRD4 O60885 1/20 0.38
▸ CREBBP Q92793 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ NOS3 P29474 2/20 0.37
▸ NOS1 P29475 2/20 0.37
▸ KCNJ1 P48048 2/20 0.37
▸ KCNH2 Q12809 2/20 0.37
▸ HRH4 Q9H3N8 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CYP3A4 P08684 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6778506 0.82 ADORA2A (0.40) GAABRD4CREBBPPPARGKDM4E
SCHEMBL6157976 0.81 NPC1 (0.59) GAANPC1RAB9ASMN1; SMN2ALOX5AP
SCHEMBL7679451 0.79 KDM5A (0.42) PPARG
SCHEMBL7168040 0.79 VNN1 (0.37) GAAALOX5APBRD4CREBBPPPARG
SCHEMBL8108669 0.79 RAB9A (0.44) GAANPC1RAB9ASMN1; SMN2KCNJ1
SCHEMBL6633568 0.78 ADRA1D (0.39) ALOX5AP
SCHEMBL7160505 0.78 NTRK1 (0.39) GAABRD4POLBMAPT
SCHEMBL6639243 0.78 ALDH1A1 (0.41) GAASMN1; SMN2KCNH2KDM4EALDH1A1
SCHEMBL1050215 0.72 BRD4 (0.36) GAANPC1RAB9ASMN1; SMN2BRD4
SCHEMBL7509579 0.70 NPC1 (0.48) GAANPC1RAB9ASMN1; SMN2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 — — EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 — — US disclosed
Send feedback